MSMiklós Szendrői

Miklós Szendrői

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Miklós Szendrői has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Tumour-Like Lesions of Bone

    by Miklós Szendrői, George Szőke


  • Variability of gait in the early postoperative period of total knee arthroplasty with different surgical technique

    by Ákos Pethes, Rita M. Kiss, Miklós Szendrői

    The purpose of this study was to work out an objective and sensitive method for the early postoperative period following total knee arthroplasty (TKA) in which analysis of the gait parameters is possible and also to investigate the influence of different surgical approaches for TKA on the gait during stepping in the first three months of the postoperative period. Three groups of patients: age-matched healthy elderly patients as a control group, patients operated upon by the conventional technique and finally by the minimally invasive technique combined with computer-assisted navigation. All three groups included ten patients. The motions of knee, shoulder and pelvis were measured by ZEBRIS ultrasound-based system preoperatively plus six and 12 weeks postoperatively. From the joint motion, the variability of cadence, and the variability of knee joint motion and that of pelvis and shoulder girdle was determined. Osteoarthritis (OA) of the knee joint and TKA using both operation techniques significantly influenced the variability of stepping parameters compared to the controls. In the early postoperative period a significant difference was detected between the two groups of the operated patients in all parameters. Our data prove that our method seems appropriate to provide objective measurement of the gait in the early postoperative period. The variability of motion of the patient groups approaches that of the healthy control group steadily, but does not reach them.


  • Open Access

    Poorly differentiated synovial sarcoma is associated with high expression of enhancer of zeste homologue 2 (EZH2)

    by Yi-Che Changchien, Péter Tátrai, Gergő Papp, Johanna Sápi, László Fónyad, Miklós Szendrői, Zsuzsanna Pápai, Zoltán Sápi

    Background: Enhancer of zeste homologue 2 (EZH2) is a polycomb group (PcG) family protein. Acting as a histone methyltransferase it plays crucial roles in maintaining epigenetic stem cell signature, while its deregulation leads to tumor development. EZH2 overexpression is commonly associated with poor prognosis in a variety of tumor types including carcinomas, lymphomas and soft tissue sarcomas. However, although the synovial sarcoma fusion proteins SYT-SSX1/2/4 are known to interact with PcG members, the diagnostic and prognostic significance of EZH2 expression in synovial sarcoma has not yet been investigated. Also, literature data are equivocal on the correlation between EZH2 expression and the abundance of trimethylated histone 3 lysine 27 (H3K27me3) motifs in tumors.Methods: Immunohistochemical stains of EZH2, H3K27me3, and Ki-67 were performed on tissue microarrays containing cores from 6 poorly differentiated, 39 monophasic and 10 biphasic synovial sarcomas, and evaluated by pre-established scoring criteria. Results of the three immunostainings were compared, and differences were sought between the histological subtypes as well as patient groups defined by gender, age, tumor location, the presence of distant metastasis, and the type of fusion gene. The relationship between EZH2 expression and survival was plotted on a Kaplan-Meier curve.Results: High expression of EZH2 mRNA and protein was specifically detected in the poorly differentiated subtype. EZH2 scores were found to correlate with those of Ki-67 and H3K27me3. Cases with high EZH2 score were characterized by larger tumor size (≥ 5cm), distant metastasis, and poor prognosis. Even in the monophasic and biphasic subtypes, higher expression of EZH2 was associated with higher proliferation rate, larger tumor size, and the risk of developing distant metastasis. In these histological groups, EZH2 was superior to Ki-67 in predicting metastatic disease.Conclusions: High expression of EZH2 helps to distinguish poorly differentiated synovial sarcoma from the monophasic and biphasic subtypes, and it is associated with unfavorable clinical outcome. Importantly, high EZH2 expression is predictive of developing distant metastasis even in the better-differentiated subtypes. EZH2 overexpression in synovial sarcoma is correlated with high H3K27 trimethylation. Thus, along with other epigenetic regulators, EZH2 may be a future therapeutic target.


  • Open Access

    Correlation between DNA ploidy, metaphase high-resolution comparative genomic hybridization results and clinical outcome of synovial sarcoma

    by Zsófia Balogh, Zsuzsanna Szemlaky, Miklós Szendrői, Imre Antal, Zsuzsanna Pápai, László Fónyad, Gergő Papp, Yi C Changchien, Zoltán Sápi

    Although synovial sarcoma is the 3rd most commonly occurring mesenchymal tumor in young adults, usually with a highly aggressive clinical course; remarkable differences can be seen regarding the clinical outcome. According to comparative genomic hybridization (CGH) data published in the literature, the simple and complex karyotypes show a correlation between the prognosis and clinical outcome. In addition, the connection between DNA ploidy and clinical course is controversial. The aim of this study was using a fine-tuning interpretation of our DNA ploidy results and to compare these with metaphase high-resolution CGH (HR-CGH) results.


  • Gait analysis following TKA: comparison of conventional technique, computer‐assisted navigation and minimally invasive technique combined with computer‐assisted navigation

    by Zoltán Bejek, Róbert Paróczai, Miklós Szendrői, Rita M. Kiss

    Purpose: There are questions concerning the influence of computer‐assisted surgery and the minimal invasive surgical technique on the outcome of total knee arthroplasty. The authors followed up the rehabilitation of patients during the first postoperative year.Methods: The ZEBRIS gait analysis system was used to obtain numerical data of kinetic and kinematic gait parameters. There were three groups of patients: patients operated by the conventional technique (Group I), patients operated on using computer‐assisted surgery (Group II), and patients who underwent the surgical procedure by a minimally invasive technique and computer‐assisted surgery (Group III). Both groups consisted of 15 patients. Gait analysis was performed preoperatively and 3, 6, 9, and 12 months after the surgery. The range of motion of the pelvis, the hip and the knee, the step width and the stride length were measured during walking.Results: Results were compared with the parameters measured in a group of healthy subjects of the same age (control group). The value of the measured parameters in Group I and in Group II reached the value of the control group 6 months after surgery. In Group III, this occurred 3 months after surgery.Conclusions: The results of the study confirm that navigation does not influence the length of rehabilitation. However, in case of minimal invasive surgery, rehabilitation is faster than in Groups I and II.


  • Diagnosis and Treatment of Soft Tissue Sarcomas

    by Miklós Szendrői, Zoltan Sápi, Kinga Karlinger, Zsuzsa Pápai


  • Adamantinoma of Long Bones: A Long-term Follow-up Study of 11 Cases

    by Miklós Szendrői, Imre Antal, Gabriella Arató

    The aim of this study was to evaluate the clinicopathological features and prognostic significances of 11 histologically proven adamantinoma cases based on an average 12,7 year long follow-up. The male: female ratio was 8:3, aged between 4 and 80 years (mean 29,3 years). The initial diagnosis at referral was other than adamantinoma in six patients (fibrous dysplasia, carcinoma metastasis, osteofibrous dysplasia, bone cyst, non-ossifying fibroma), referring to the differential diagnostic problems. All tumors were localized to the mid part of tibia. By histological evaluation, basaloid pattern on a background of fibrotic stroma dominated in six patients, while spindle and squamous features were less frequently seen. All adamantinomas were positive for cytokeratins often in coexpression with vimentin. No correlation was experienced between histology and clinical outcome. Intralesional curettage (2 pts) was followed by recurrence of the tumor. Wide resection was performed in eight patients with reconstruction using intercalary fibula autografts in seven patients. Reconstruction-related complications occurred in two third of the cases, all of them could however be controlled by repeated surgery. Six recurrences occurred in four patients, two of these recurrences occurred 20 and 16 years after initial surgery. One patient died 9 years after recognition of the tumor of pulmonary metastases. Adamantinoma of the long bones is a low grade malignant tumor, which clinical outcome is difficult to predict based on histology or surgical stage of the tumor. Wide surgical margin, e.g. resection the tumor reduces the rate of recurrence. This study underlines that recurrences do occur even decades after recognition the tumor, therefore a life-long follow-up of the patient is necessary.


  • Open Access

    Bone tumours

    by Miklós A. Szendrői